Figure 5.
Change from baseline in number of SBMs per week by study week and treatment (ITT population). aP < 0.05 vs placebo; Mean number of SBMs per week at baseline: tegaserod 2.33; placebo 2.26.
Change from baseline in number of SBMs per week by study week and treatment (ITT population). aP < 0.05 vs placebo; Mean number of SBMs per week at baseline: tegaserod 2.33; placebo 2.26.